Blog
RSS FeedPosted by Michael Wonder on 20 May 2019
Health Technology Assessment Consumer Consultative Committee March 2019 meeting communiqué
20 May 2019 - A communiqué from the March 2019 meeting of the HTA Consumer Consultative Committee has been published. ...
Posted by Michael Wonder on 20 May 2019
PBS Pharmaceuticals in Hospitals Review
20 May 2019 - The Department of Health completed the PBS Pharmaceuticals in Hospitals Review to better understand how PBS medicines ...
Posted by Michael Wonder on 19 May 2019
Australians want cheaper medicines quicker
20 May 2019 - Just last week, an 18-year-old woman with a rare cancer was staring down the barrel of ...
Posted by Michael Wonder on 17 May 2019
Health technology assessment challenges in oncology: 20 years of Value in Health
16 May 2019 - Oncology treatments have changed from chemotherapies to targeted therapies and more recently immuno-oncology. ...
Posted by Michael Wonder on 16 May 2019
A $1 discount on prescription medicines is under threat
16 May 2019 - Australians are likely to pay more for prescription medicines no matter who wins the election on ...
Posted by Michael Wonder on 16 May 2019
Sigma Healthcare leadership says it has received no worker reports of medicine mishandling
16 May 2019 - Sigma Healthcare's chief executive Mark Hooper has told investors that the company takes its obligations to ...
Posted by Michael Wonder on 15 May 2019
Sigma Healthcare to face investor questions over claims it mishandled prescription drugs
15 May 2019 - Pharmaceutical supplier Sigma Healthcare will face shareholder questions over claims that it failed to properly handle ...
Posted by Michael Wonder on 14 May 2019
Analysis of sponsor hearings on PBAC decision making
14 May 2019 - Original research conducted by Melinda Flowers, Sean Lybrand and myself has been published on-line in the ...
Posted by Michael Wonder on 13 May 2019
Australia's GBMA launches hub for biosimilar education
13 May 2019 - In 2018, the Generic Biosimilar Medicines Association was awarded the Biosimilar Education Grant by the Australian government ...
Posted by Michael Wonder on 10 May 2019
Speed up cancer funding, ALP told
11 May 2019 - The head of Australian drug company Specialised Therapeutics, Carlo Montagner, has warned that Bill Shorten’s cancer ...
Posted by Michael Wonder on 10 May 2019
PBS summary of changes for 1 June 2019
10 May 2019 - The Prime Minister has announced an 18 May 2019 federal election and as such, the Department ...
Posted by Michael Wonder on 10 May 2019
What do transformational shifts mean in terms of ultimate outcomes and ‘value’ of medicines?
9 May 2019 - Emerging ‘one-time’ curative therapies create important new options for patients living with difficult and incurable health ...
Posted by Michael Wonder on 09 May 2019
Cancer specialists ‘won’t increase’ fees under Labor plan
9 May 2019 - Australia’s cancer doctors have rejected Scott Morrison’s claims they will charge patients higher fees under Labor’s ...
Posted by Michael Wonder on 08 May 2019
Medicines Australia welcomes ALP R&D investment pledge
8 May 2019 - Medicines Australia welcomes today’s announcement from the Australian Labor Party to reform the Research and Development ...
Posted by Michael Wonder on 04 May 2019
Health funds want to raise a tax penalty to force you to buy their products
4 May 2019 - A $900 plus tax penalty to force the rich to buy private health insurance is now ...